Guardant Health Overview

  • Founded
  • 2012
Founded
  • Status
  • Public
  • Employees
  • 864
Employees
  • Stock Symbol
  • GH
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $120.20
  • (As of Friday Closing)

Guardant Health General Information

Description

Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. The company offers Guardant 360, a blood-based (liquid biopsy) test for treatment selection in advanced stage cancer, and Guardant Omni, a broader gene panel for immuno-oncology research. The company's pipeline includes Lunar-1, for cancer recurrence detection in survivors, and Lunar-2, a liquid biopsy for early detection of cancer in higher-risk individuals, with an initial focus on colorectal cancer. Additionally, Guardant offers research development services. The United States accounts for 90% of total revenue, and other markets the remaining 10%.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Laboratory Services (Healthcare)
Stock Exchange
NAS
Primary Office
  • 505 Penobscot Drive
  • Redwood City, CA 94063
  • United States
+1 (855) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Guardant Health Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$120.20 $123.69 $77.50 - $181.07 $12.2B 101M 959K -$3.38

Guardant Health Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 14,446,873 11,974,557 6,861,490 3,494,318
Revenue 297,885 286,730 214,375 90,639
EBITDA (320,041) (235,244) (70,872) (81,104)
Net Income (335,712) (253,783) (75,651) (85,063)
Total Assets 2,346,741 2,271,781 962,535 587,403
Total Debt 1,350,223 854,489 40,396 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Guardant Health Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Guardant Health‘s full profile, request access.

Request a free trial

Guardant Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Guardant Health‘s full profile, request access.

Request a free trial

Guardant Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research
Diagnostic Equipment
Redwood City, CA
864 As of 2020
00000
000000 - 000 00000

00000000

e magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip e
0000000000 000000000
Irvine, CA
00 As of 0000
000.00
000000000 000.00

00000000

olor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore mag
0000000000 000000000
Boulder, CO
000 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Guardant Health Competitors (38)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OncoCyte Pending Transaction (M&A) Irvine, CA 00 000.00 000000000 000.00
00000000 Formerly VC-backed Boulder, CO 000 00000 00000000 00000
000000000 00000 Venture Capital-Backed Siena, Italy 00 0000000000 0
000000 00000000000 Formerly VC-backed Friendswood, TX 000 00000 00000000 00000
00000000 000000000 Venture Capital-Backed Wuxi, China 00000 00000000000 00000
You’re viewing 5 of 38 competitors. Get the full list »

Guardant Health Executive Team (24)

Name Title Board Seat Contact Info
Helmy Eltoukhy Ph.D Chief Executive Officer & Board Member
Michael Bell Chief Financial Officer
AmirAli Talasaz Ph.D Chairman & Chief Operating Officer, Operations
Michael Wiley JD Chief Legal Officer, Legal
Chris Freeman Chief Commercial Officer
You’re viewing 5 of 24 executive team members. Get the full list »

Guardant Health Board Members (10)

Name Representing Role Since
AmirAli Talasaz Ph.D Guardant Health Chairman & Chief Operating Officer, Operations 000 0000
Bahija Jallal Ph.D Self Board Member 000 0000
Helmy Eltoukhy Ph.D Guardant Health Chief Executive Officer & Board Member 000 0000
Ian Clark Self Board Member 000 0000
Samir Kaul Khosla Ventures Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Guardant Health Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Guardant Health Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 21-May-2020 0000 00000 00.000 Discovery Tools (Healthcare)
0000000000 000 24-Apr-2019 000000000000000000 0000 Biotechnology 0000000 0000000 00.0
Guardant Health AMEA 01-Apr-2018 Joint Venture 0000 Biotechnology 00000 0000
To view Guardant Health’s complete investments and acquisitions history, request access »